<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: <z:chebi fb="240" ids="33364,33400">Platinum</z:chebi> agents have shown to be effective in the treatment of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We assessed whether single nucleotide polymorphisms (SNPs) in GSTP1, ERCC1 Asn118Asn and ERCC2 Lys751Gln might predict the overall survival in patients receiving <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi>-based chemotherapy in a Chinese population </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: SNPs of GSTP1, ERCC1 Asn118Asn and ERCC2 Lys751Gln in 335 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients were assessed using TaqMan nuclease assays </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: At the time of final analysis on Nov </plain></SENT>
<SENT sid="4" pm="."><plain>2011, the median follow-up period was 37.7 months (range from 1 to 60 months) </plain></SENT>
<SENT sid="5" pm="."><plain>A total of 229 patients died during follow-up </plain></SENT>
<SENT sid="6" pm="."><plain>Our study showed GSTP1 Val/Val (HR=0.44, 95% CI=0.18-0.98), ERCC1 C/C (HR=0.20, 95% CI=0.10-0.79) and ERCC2 G/G (HR=0.48, 95% CI=0.19-0.97) to be significantly associated with better survival of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>GSTP1 Val/Val, ERCC1 C/C and ERCC2 G/G were also related to longer survival among patients with <z:hpo ids='HP_0003003'>colon cancer</z:hpo>, with HRs (95% CIs) of 0.41 (0.16-0.91), 0.16 (0.09-0.74) and 0.34 (0.16-0.91), respectively </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: GSTP1, GSTP1, ERCC1 Asn118Asn and ERCC2 Lys751Gln genotyping might facilitate tailored <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi>-based chemotherapy for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
</text></document>